Abstract
A purpose-designed anthraquinone-monoclonal antibody (anti-sialyl Lewis A (sLea) mAb) hybrid 6 selectively bound to and effectively degraded the target glycoprotein, HSA (human serum albumin)-sLea conjugate 4. Degradation was achieved using long wavelength UV light irradiation in the absence of any additives and under neutral conditions. Furthermore, the hybrid 6 exhibited selective photo-cytotoxicity against the sLea positive cancer cells A431 and WiDr cells only upon photo-irradiation.
Original language | English |
---|---|
Pages (from-to) | 1224-1228 |
Number of pages | 5 |
Journal | MedChemComm |
Volume | 7 |
Issue number | 6 |
DOIs | |
Publication status | Published - 2016 |
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Pharmacology
- Pharmaceutical Science
- Drug Discovery
- Organic Chemistry